TEVA AND TRUMP ADMINISTRATION ANNOUNCE INTENT TO REACH AGREEMENT ON AFFORDABLE MEDICINES AND U.S. SUPPLY-CHAIN SECURITY, WITH TEVA OFFERING A DEDICATED API RESERVE AND CONTINUED U.S. MANUFACTURING INVESTMENT.
TEVA $TEVA AND TRUMP ADMINISTRATION ANNOUNCE INTENT TO REACH DRUG-PRICING DEAL
The company says it remains in active discussions with the administration on an agreement anchored in all four of the president's drug pricing priorities, covering affordable medicines and US supply chain security. Conditions of the negotiation remain confidential, per the company.
JUST IN: Teva and the Trump administration reveal they intend to reach a drug-pricing deal focused on lower costs and stronger U.S. supply chain security.
All these stocks hit new 52 WEEK HIGHS at some point today
AMD $AMD
Moderna $MRNA
Warner Bros. Discovery $WBD
Amneal Pharmaceuticals $AMRX
Teva Pharmaceutical $TEVA
Semtech $SMTC
Cloudflare $NET
Rubrik $RBRK
Valero Energy $VLO
Halozyme Therapeutics $HALO
HF Sinclair $DINO
Marathon Petroleum $MPC
Ultrapar Participações $UGP
Twilio $TWLO
Twist Bioscience $TWST
10x Genomics $TXG
Natera $NTRA
Calumet $CLMT
CVR Energy $CVI
Bank of Nova Scotia $BNS
F5 $FFIV